NCT00459251|Completed
Pharmacogenetics Study in Taiwan's Ethnic Groups
The Pharmacogenetics Study of Drug-Metabolising Enzyme Genetic Polymorphisms in Aboriginal and Minnan/Hakka Ethnic Groups in Taiwan
Loading search results
The Pharmacogenetics Study of Drug-Metabolising Enzyme Genetic Polymorphisms in Aboriginal and Minnan/Hakka Ethnic Groups in Taiwan
Sponsor study identifier
observational
350
1 country
1
Study Start
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
April 2007
Actual (reported)This main purpose of this study is to understand the difference and distribution of drug-metabolizing enzyme genetic polymorphisms among Taiwan ethnicities. The subjects of study include Atayal, Pawlan, Yami, Tsou, Ami, Minnan and Hakka. We anticipate establishing a reference for the clinical medication in various ethnic groups according to the difference and distribution of the genetic polymorphisms.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2007
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
April 2007
Actual (reported)April 10, 2007
Actual (reported)April 11, 2007
Actual (reported)Contact the study team to confirm eligibility.
Mackay Memorial Hospital
Taipei, 100, Taiwan
Chu CC, Lin M, Nakajima F, Lee HL, Chang SL, Juji T, Tokunaga K. Diversity of HLA among Taiwan's indigenous tribes and the Ivatans in the Philippines. Tissue Antigens. 2001 Jul;58(1):9-18. doi: 10.1034/j.1399-0039.2001.580102.x.
Li-Jiuan Shen, Ph.D.
School of Pharmacy, National Taiwan University
First Submitted
April 10, 2007
First Posted
April 11, 2007
Study Start
December 2006
Date type not reportedThis date has not been verified as actual or estimated.
Study Completion
April 2007
Actual (reported)Catecholamines Can Attenuate Intermittent Hypoxia-Induced Expression of TNF in Human Monocytes
Last Updated
April 11, 2007
Record last verified: 2007-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: